Oneview Healthcare PLC · ASX:ONE
Oneview Healthcare — H1 2023 Earnings Presentation
25 slides from Oneview Healthcare's earnings presentation, Aug 29, 2023
Slide 1: Half Year 2023 Results
29th August 2023 Half Year 2023 Results Oneview Healthcare PLC | ABRN: 610 611 768
Slide 2: Legal disclaimer
Legal disclaimer This presentation contains general information about the activities of Oneview Healthcare PLC (ABRN 610 611 768) (Oneview or Company) which is current as at 28 August 2023. It is in summary form and does not purport to be complete. It presents financial information on a statutory ba
Slide 3: Our vision
Our vision To power personalised, exemplary care experiences 3
Slide 4: Agenda
Agenda H1 23 in Review 5 Product Innovation 12 H1 23 Financial Results 16 Outlook 20 Q&A 25 4
Slide 5: H1 23 in Review
H1 23 in Review Onéview>
Slide 6: H1 Overview
H1 23 Overview • Excluding once-off income and costs from settlement of the Regis legal case reflected in 2022 of €1.29 million, the loss from continuing operations reduced by 30%. • Post-pandemic sales momentum continues to build. This half year represented the largest volume of net new contract si
Slide 7: H1 Financial Highlights
H1 23 Financial Highlights Recurring Revenue €3.32 ▲ 11% Total revenue €4.36 ▲ 11% Gross margin €2.83 ▲ 14% Gross margin % 65% ▲ 2% Operating Expenditure €5.68 19% Operating EBITDA (€3.97) 17% Net loss after tax (€4.46) 12% Net loss exc. Regis proceeds 30% 1 Excluding depreciation, amortisation, imp
Slide 8: H1 Highlights
H1 23 Highlights 20% growth in live beds to 5 new customers for Cloud BYOD development 11,4471. Accelerated products, including first commenced and ahead of deployment scheduled for European Cloud customer schedule H2 2023 onwards 16% growth in contracted Strong sales pipeline, Value Framework enhan
Slide 9: New customer wins
New customer wins North America ANZ Europe €9.9m €1.6m Aggregate Aggregate TCV1 ARR2 1 Minimum Total Contract Value (TCV) for the new customer wins 2 Aggregate Annualised Recurring Revenue (ARR) for the new customer wins 9
Slide 10: Expansions/Upgrades
Expansions/Upgrades 600 bed upgrade to Gen 3 and contract extended for a further 3 years 1,045 bed expansion now substantially complete, on- schedule, having commenced in January 2 hospitals out of the 10 expansion hospital sites now live – installation in 3rd & 4th hospitals now underway 10
Slide 11: Operational Highlights
W Operational Highlights ISO certification retained, with audits passed successfully 30% reduction in office rental costs, with offices downsized to reflect post-pandemic hybrid working model oneviewhealthcare.com Supply chains stabilized, enabling installation rates to increase Over 1,000 beds depl
Slide 12: Product Innovation
Product Innovation Onéview>
Slide 13: Product Innovation
Leveraging Electronic Health Record integration to provide contextual information, when and where it’s needed, to support great patient care - expanding the value proposition and increasing recurring revenue potential. Digital Door Sign oom 2s RoonPhow 853623 QNESTIGW> Lanquge EmtehProncuns Shier Pr
Slide 14: BYOD Execution Update
BYOD Execution Update • BYOD Phase 1 in delivery and expected to complete in Q4 2023, ahead of schedule • Leveraging resource augmentation to accelerate delivery and manage operating costs • Sales and marketing activities commencing Q3 2023 • BYOD Pilot to commence in Q4 2023, to measure engagement
Slide 15: Empowering patients and optimising hospital care with a mobile experience
Empowering patients and optimising hospital care with a seamless, personalised and mobile experience can produce benefits, potentially including the following
Slide 16: H1 Financial Results
H1 23 Financial Results Onéview>
Slide 17: HY 23 Income Statement
HY 23 Income Statement VARIANCE % € millions • Recurring revenue increase of 11%. Increased installation HY23 HY22 (HY23 – HY22) rates coming out of Covid and facilitated by faster Cloud Recurring revenue 3.32 2.99 11% deployments Non-recurring revenue 1.04 0.92 12% Total revenue 4.36 3.91 11% • Tot
Slide 18: HY 23 Balance Sheet
HY 23 Balance Sheet • Cash balance of €2.6m as at 30 June 2023. Recent as at as at € millions Equity raise of A$22.8m (€13.6m) before costs from a 30-Jun-23 31-Dec-22 Placement and an oversubscribed SPP has provided Assets strong platform for growth Cash and cash equivalents 2.61 6.41 Trade and othe
Slide 19: HY 23 Cash Flow
HY 23 Cash Flow € millions HY23 HY22 Cash flows from operating activities • Net cash of €2.6m at 30 June 2023. Recent Equity raise of Receipts from customers 4.16 2.83 A$22.8m (€13.6m) before costs has provided cash runway Legal claim settlement proceeds - 1.36 to capitalise on growth opportunities
Slide 20: Outlook
20 Outlook Onéview>
Slide 21: Market drivers
Market drivers Macro drivers Micro drivers • Virtual nursing: bedside technology enables virtual • Staffing challenges: nursing staff shortages and nursing programs, which are increasing at a rate of 34% staffing costs require new approaches to care delivery, in the US market5. enabled by technology
Slide 22: Care Experience Platform
Care Experience Platform Unifying a hospital’s systems, content and services into one digital platform Existing revenue stream New revenue generating opportunities Patient TV/Tablet My Stay Overview Digital Door Sign Patient’s Device (In development) Powered by integrations Electronic Health Virtual
Slide 23: Baxter VAR Execution Update
Baxter VAR Execution Update * Partnership execution commenced * 7 workstreams in progress to launch partnership, with weekly engagement * Analysis of Baxter install base completed to identify high prospect opportunities * Installation of CXP in Baxter's ‘Customer Experience Centers’ in coming weeks
Slide 24: Value Story Relaunch
Value Story Relaunch BYOD Beds contracted/currently in negotiations ~3,000-5,000 2,345 Potential addition of beds currently in 16,058 negotiation will give ONE a clear path to cash flow breakeven Contracting these beds is expected to bring ONE to ~AUD$18m of recurring revenue Contracted Negotiations
Slide 25: Questions
25 Questions Onéview>